BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 25151562)

  • 1. Antiretroviral therapy: current drugs.
    Pau AK; George JM
    Infect Dis Clin North Am; 2014 Sep; 28(3):371-402. PubMed ID: 25151562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Key Principles of Antiretroviral Pharmacology.
    Dionne B
    Infect Dis Clin North Am; 2019 Sep; 33(3):787-805. PubMed ID: 31395145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beginning antiretroviral therapy for patients with HIV.
    Johnson JA; Sax PE
    Infect Dis Clin North Am; 2014 Sep; 28(3):421-38. PubMed ID: 25151564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial Antiretroviral Therapy in an Integrase Inhibitor Era: Can We Do Better?
    Kelly SG; Masters MC; Taiwo BO
    Infect Dis Clin North Am; 2019 Sep; 33(3):681-692. PubMed ID: 31239093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Options in HIV therapy: present and future].
    Röling J; Draenert R; Goebel FD
    Internist (Berl); 2005 Aug; 46(8):892-4, 896-8. PubMed ID: 15968521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Drug Monitoring of HIV Antiretroviral Drugs in Pregnancy: A Narrative Review.
    O'Kelly B; Murtagh R; Lambert JS
    Ther Drug Monit; 2020 Apr; 42(2):229-244. PubMed ID: 32004247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status and challenges of antiretroviral research and therapy.
    Esté JA; Cihlar T
    Antiviral Res; 2010 Jan; 85(1):25-33. PubMed ID: 20018390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral drugs.
    De Clercq E
    Curr Opin Pharmacol; 2010 Oct; 10(5):507-15. PubMed ID: 20471318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapse of Kaposi's Sarcoma and HHV-8 viremia in an HIV-infected patient switching from protease inhibitor to integrase inhibitor-based antiretroviral therapy.
    Simonetti FR; Ricaboni D; Cattaneo D; Micheli V; Rusconi S; Gervasoni C
    J Clin Virol; 2016 Jan; 74():75-7. PubMed ID: 26682615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New and investigational antiretroviral drugs for HIV infection: mechanisms of action and early research findings.
    Saag MS
    Top Antivir Med; 2012 Dec; 20(5):162-7. PubMed ID: 23363694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral treatment of human immunodeficiency virus infection: update for 2003.
    Postic B; Horvath JA; Talwani R
    J S C Med Assoc; 2003 Jun; 99(6):148-53. PubMed ID: 12886699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HIV infection, antiretroviral therapy, and endothelium].
    Hürlimann D; Weber R; Enseleit F; Lüscher TF
    Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New antiretroviral drugs and approaches to HIV treatment.
    Paredes R; Clotet B
    AIDS; 2003; 17 Suppl 4():S85-96. PubMed ID: 15080184
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiretrovirals, part 1: overview, history, and focus on protease inhibitors.
    Wynn GH; Zapor MJ; Smith BH; Wortmann G; Oesterheld JR; Armstrong SC; Cozza KL
    Psychosomatics; 2004; 45(3):262-70. PubMed ID: 15123854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in antiretroviral therapy.
    Olender S; Wilkin TJ; Taylor BS; Hammer SM
    Top Antivir Med; 2012; 20(2):61-86. PubMed ID: 22710908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is Antiretroviral Two-Drug Regimen the New Standard for HIV Treatment in Naive Patients?
    Dupont E; Yombi JC
    AIDS Rev; 2019; 21(3):143-156. PubMed ID: 31532398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in Africa.
    Ciaffi L; Koulla-Shiro S; Sawadogo A; le Moing V; Eymard-Duvernay S; Izard S; Kouanfack C; Ngom Gueye NF; Fobang AA; Reynes J; Calmy A; Delaporte E;
    AIDS; 2015 Jul; 29(12):1473-81. PubMed ID: 26244387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cabotegravir plus rilpivirine, once a day, after induction with cabotegravir plus nucleoside reverse transcriptase inhibitors in antiretroviral-naive adults with HIV-1 infection (LATTE): a randomised, phase 2b, dose-ranging trial.
    Margolis DA; Brinson CC; Smith GHR; de Vente J; Hagins DP; Eron JJ; Griffith SK; Clair MHS; Stevens MC; Williams PE; Ford SL; Stancil BS; Bomar MM; Hudson KJ; Smith KY; Spreen WR;
    Lancet Infect Dis; 2015 Oct; 15(10):1145-1155. PubMed ID: 26201299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in antiretroviral therapy in HIV infection.
    Arora DR; Gautam V; Gill PS; Mishra N
    J Indian Med Assoc; 2010 Jan; 108(1):29-34. PubMed ID: 20839577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Choosing Initial Antiretroviral Therapy: Current Recommendations for Initial Therapy and Newer or Investigational Agents.
    Gulick RM
    Top Antivir Med; 2015; 23(4):128-31. PubMed ID: 26713502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.